Chief Medical Officer
Dr. Lopatin was a co-founder of Assembly Pharmaceuticals, Inc. prior to its merger with a subsidiary of Assembly Biosciences, Inc. (formerly known as Ventrus Biosciences, Inc.) Dr. Lopatin currently serves as the Chief Medical Officer. Dr. Lopatin graduated cum laude with distinction from Cornell University and received his MD degree from the University of Medicine and Dentistry-New Jersey Medical School, where he was awarded the Stanley S. Bergen medal of excellence. Following Internal Medicine training at the University of Washington and NYU, Dr. Lopatin completed a fellowship in infectious diseases at the National Institutes of Health. Prior to Assembly, he was the Senior Director for Clinical and Translational Research in Liver Disease at Gilead Sciences. At Roche, Dr. Lopatin was a Translational Medical Leader focused on chronic infectious diseases and immunology. Earlier, he was an Associate Director in Hepatology at Schering Plough. Dr. Lopatin has published extensively, especially on HBV and immunology, and is a co-author of multiple patents for the diagnosis and treatment of viral hepatitis. Dr. Lopatin was a mentor in the Theil 20 Under 20 Fellowship and a Fellow in the UPMC Emerging Leaders in Biosecurity Initiative.